SCHEMBL17784486

SCHEMBL17784486

Cc1ccc(Br)cc1F.[MgH2]

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ DGAT1 O75907 1/20 0.42
▸ ACHE P22303 1/20 0.40
▸ KDM1A O60341 2/20 0.39
▸ KDM1B Q8NB78 1/20 0.39
▸ MAPK1 P28482 1/20 0.37
▸ PYCR1 P32322 1/20 0.37
▸ SIRT2 Q8IXJ6 1/20 0.37
▸ NMT1 P30419 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NISCH Q9Y2I1 1/20 0.35
▸ APLNR P35414 2/20 0.34
▸ TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL47042 0.97 — —
Fluoride SCHEMBL27726514 0.95 HDAC1 (0.44) HDAC1HDAC6ALDH1A1MAPTMEN1
Hydrochloric Acid SCHEMBL27656812 0.95 HDAC1 (0.44) HDAC1HDAC6ALDH1A1MAPTMEN1
SCHEMBL5347385 0.80 ACHE (0.40) ALDH1A1MAPTMEN1KMT2ADGAT1
SCHEMBL30337581 0.77 — —
SCHEMBL13470 0.77 — —
SCHEMBL2347585 0.76 DGAT1 (0.46) ALDH1A1MAPTMEN1KMT2ADGAT1
SCHEMBL3735885 0.76 ALDH1A1 (0.43) ALDH1A1MAPTMEN1KMT2AACHE
SCHEMBL6246291 0.74 ALDH1A1 (0.44) HDAC1HDAC6ALDH1A1MAPTMEN1
SCHEMBL8146926 0.73 CYP2A6 (0.46) ALDH1A1MAPTMEN1KMT2ADGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3224269-A1 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS Sage Therapeutics, Inc. (US) 2017-10-04 — — EP disclosed
WO-2016082789-A1 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS SAGE THERAPEUTICS, INC. (US) 2016-06-02 — — WO disclosed
CN-1167687-C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors ���Ͽع����޹�˾ 2004-09-22 — — CN disclosed
CN-1277605-A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors ABBOTT LAB (US) 2000-12-20 — — CN disclosed
Send feedback